T ACCESS
LIVE

Serial Number

87277841

Owner

H. Lundbeck A/S

Attorney

Maren C. Perry

Filing Date

Dec 22, 2016

Add to watchlist:

No watchlists yet
View on USPTO

T ACCESS Trademark

Serial Number: 87277841 • Registration: 5333339

T ACCESS is a trademark filed by H. Lundbeck A/S on December 22, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

H. Lundbeck A/S (398 trademarks)

Ottiliavej 9
DK-2500 Copenhagen-Valby , DK

Entity Type: 03

Trademark Details

Filing Date

December 22, 2016

Registration Date

November 14, 2017

Published for Opposition

August 29, 2017

Goods & Services

[ Educational services, namely, providing classes, courses, and seminars in the field of medicine and disease prevention; providing medical training; arranging and conducting seminars, educational conferences, symposiums, workshops and courses in the field of medicine and disease prevention; educational services, namely, providing classes, seminars, workshops, and training in the fields of scientific research and development in the fields of pharmaceuticals, science, pharmaceutical clinical studies, tests and trials, medical diagnostics, medicine, pharmaceuticals, medical disorders, diseases, and disease treatment and prevention; providing the aforementioned services electronically, via cable or Internet or other electronic media; arranging and conducting in-person educational forums in the fields of medicine and pharmaceuticals; on-line training programs in the fields of medicine and pharmaceuticals; providing temporary use of online non-downloadable publications in the nature of books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, and teaching and educational curriculum in the fields of medical and pharmaceutical research and development ]

[ Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes ]

Medical services; healthcare services; therapeutic clinical services in the field of brain and central nervous systems diseases and disorders; providing medical and healthcare information; providing information in the field of the therapeutic properties of pharmaceuticals; psychiatry and clinical psychology services in the fields of central nervous system diseases and disorders; medical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing medical information in the field of diagnostics, medicine, pharmaceuticals, medical disorders, diseases, and disease treatment and prevention; providing online medical data and analyses designed to provide patients and clients with customized medical information regarding medical dosing, medical diagnoses, therapeutic counseling services, and non-surgical medical management of diseases and medical disorders

[ Scientific and technological services, namely, research and design in the field of medicine; industrial analysis and research services in the field of pharmaceuticals; providing temporary use of online non-downloadable software for accessing an online searchable database in the fields of medical research and development, science, clinical tests and trials, medical diagnostics, medicine, pharmaceuticals, medical disorders, diseases, and disease treatment and prevention; pharmaceutical research and development; scientific and technological services, namely, research in the fields of medical disorders, diseases, disease prevention, central nervous system, neurological disorders, and central nervous system disorders, diseases, and related pharmaceuticals; medical research, namely, conducting medical trials and tests for others in the field of pharmaceuticals; conducting clinical research, trials, and testing for others in the field of pharmaceuticals; medical diagnostic research and tests and clinical trials for others; providing medical and pharmaceutical information in the field of research and development, science, clinical trials and tests ]

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 22, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 22, 2024 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Mar 22, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 22, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 22, 2024 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jan 23, 2024 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Jan 23, 2024 8.PR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 23, 2024 APRE
TEAS SECTION 8 RECEIVED
Nov 13, 2023 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 14, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 14, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 29, 2017 NPUB
PUBLISHED FOR OPPOSITION
Aug 29, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 9, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 19, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 19, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 19, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 19, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 19, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 5, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 5, 2017 CRFA
ASSIGNED TO LIE
Jun 29, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 1, 2017 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 1, 2017 TCCA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 29, 2017 GNRN
NON-FINAL ACTION E-MAILED
Mar 29, 2017 GNRT
NON-FINAL ACTION WRITTEN
Mar 29, 2017 CNRT
ASSIGNED TO EXAMINER
Mar 23, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 6, 2017 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 5, 2017 NWOS
NEW APPLICATION ENTERED
Dec 27, 2016 NWAP